Divergent perceptions of barriers to diabetic retinopathy screening among patients and care providers, Los Angeles, California, 2014-2015

Preventing Chronic Disease

Volumn 13, Issue 10, 2016, Pages

  Lu, Yang ^a   Serpas, Lilian ^a   Genter, Pauline ^a   Anderson, Betty ^a   Campa, David ^b   Ipp, Eli ^c  

^a LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b LOS ANGELES COUNTY DEPARTMENT OF HEALTH SERVICES   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANCESTRY GROUP; ATTITUDE TO HEALTH; CALIFORNIA; COMMUNICATION BARRIER; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; FEMALE; HEALTH CARE DELIVERY; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; QUESTIONNAIRE; SAFETY NET HOSPITAL; STATISTICS AND NUMERICAL DATA; TRAFFIC AND TRANSPORT;

COMMUNICATION BARRIERS; CONTINENTAL POPULATION GROUPS; CROSS-SECTIONAL STUDIES; DIABETIC RETINOPATHY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HUMANS; LOS ANGELES; MALE; MASS SCREENING; MIDDLE AGED; SAFETY-NET PROVIDERS; SURVEYS AND QUESTIONNAIRES; TRANSPORTATION;

EID: 84994417396     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: 10.5888/pcd13.160193     Document Type: Article

References (29)

1. Centers for Disease Control and Prevention. Blindness and visionimpairment. 2011. http://www.cdc.gov/healthcommunication/ToolsTemplates/EntertainmentEd/Tips/Blindness.html. Accessed October 1, 2015.
2. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol 2012;96(5):614-8.
3. Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35(3):556-64.
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329(14):977-86.
5. Kamran MA. Association between high risk foot, retinopathy and HbA1C in Saudi diabetic population. Pak J Physiol. 2010; 6(2):21-8.
6. American Academy of Ophthalmology Retina/Vitreous Panel. Preferred practice pattern guidelines. Diabetic retinopathy. San Francisco (CA): American Academy of Ophthalmology; 2014.
7. American Diabetes Association. Microvascular complications and foot care. Diabetes Care 2015;38(Suppl):S58-66.
8. Shi Q, Zhao Y, Fonseca V, Krousel-Wood M, Shi L. Racial disparity of eye examinations among the US working-age population with diabetes: 2002-2009. Diabetes Care 2014; 37(5):1321-8.
9. Zhang X, Cotch MF, Ryskulova A, Primo SA, Nair P, Chou CF, et al. Vision health disparities in the United States by race/ethnicity, education, and economic status: findings from two nationally representative surveys. Am J Ophthalmol 2012; 154(6, Suppl):S53-62.e1, 62.e1.
10. Muñoz B, O'Leary M, Fonseca-Becker F, Rosario E, Burguess I, Aguilar M, et al. Knowledge of diabetic eye disease and vision care guidelines among Hispanic individuals in Baltimore with and without diabetes. Arch Ophthalmol 2008; 126(7):968-74.
11. Mensing C, Boucher J, Cypress M, Weinger K, Mulcahy K, Barta P, et al. National standards for diabetes self-management education. Diabetes Care 2000;23(5):682-9.
12. Dervan E, Lillis D, Flynn L, Staines A, O'Shea D. Factors that influence the patient uptake of diabetic retinopathy screening. Ir J Med Sci 2008;177(4):303-8.
13. van Eijk KN, Blom JW, Gussekloo J, Polak BC, Groeneveld Y. Diabetic retinopathy screening in patients with diabetes mellitus in primary care: incentives and barriers to screening attendance. Diabetes Res Clin Pract 2012;96(1):10-6.
14. Ellish NJ, Royak-Schaler R, Passmore SR, Higginbotham EJ. Knowledge, attitudes, and beliefs about dilated eye examinations among African-Americans. Invest Ophthalmol Vis Sci 2007;48(5):1989-94.
15. Lindenmeyer A, Sturt JA, Hipwell A, Stratton IM, Al-Athamneh N, Gadsby R, et al. Influence of primary care practices on patients" uptake of diabetic retinopathy screening: a qualitative case study. Br J Gen Pract 2014;64(625):e484-92.
16. Varma R, Mohanty SA, Deneen J, Wu J, Azen SP. Burden and predictors of undetected eye disease in Mexican-Americans: the Los Angeles Latino Eye Study. Med Care 2008; 46(5):497-506.
17. Sheppler CR, Lambert WE, Gardiner SK, Becker TM, Mansberger SL. Predicting adherence to diabetic eye examinations: development of the Compliance with Annual Diabetic Eye Exams Survey. Ophthalmology 2014; 121(6):1212-9.
18. Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA. Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. Ophthalmology 2003; 110(10):1952-9.
19. Durand M-A, Carpenter L, Dolan H, Bravo P, Mann M, Bunn F, et al. Do interventions designed to support shared decisionmaking reduce health inequalities? A systematic review and meta-analysis. PLoS One 2014;9(4):e94670.
20. Sloan FA, Brown DS, Carlisle ES, Picone GA, Lee PP. Monitoring visual status: why patients do or do not comply with practice guidelines. Health Serv Res 2004;39(5):1429-48.
21. Ray KN, Chari AV, Engberg J, Bertolet M, Mehrotra A. Disparities in time spent seeking medical care in the United States. JAMA Intern Med 2015;175(12):1983-6.
22. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24(6):1069-78.
23. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001;63(4):619-30.
24. Sieu N, Katon W, Lin EH, Russo J, Ludman E, Ciechanowski P. Depression and incident diabetic retinopathy: a prospective cohort study. Gen Hosp Psychiatry 2011;33(5):429-35.
25. Nguyen TT, Wong TY, Islam FM, Hubbard L, Ajilore O, Haroon E, et al. Evidence of early retinal microvascular changes in patients with type 2 diabetes and depression. Psychosom Med 2010;72(6):535-8.
26. Petrova D, Garcia-Retamero R, Catena A. Lonely hearts don't get checked: on the role of social support in screening for cardiovascular risk. Prev Med 2015;81:202-8.
27. Champion VL, Skinner CS. Differences in perceptions of risk, benefits, and barriers by stage of mammography adoption. J Womens Health (Larchmt) 2003;12(3):277-86.
28. Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Cavaliere D, Di Nardo B, et al. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care 2001;24(11):1870-7.
29. Lu Y, Serpas L, Genter P, Mehranbod C, Campa D, Ipp E. Disparities in diabetic retinopathy screening rates within minority populations: differences in reported screening rates among African American and Hispanic patients. Diabetes Care 2016;39(3):e31-2.